Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Parentheticals)

v3.24.1.u1
Consolidated Balance Sheets (Parentheticals) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
 [1]
Accounts receivable, net of allowance (in Dollars) $ 58 $ 85
Preferred stock value, par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, liquidation preference (in Dollars) $ 18,075  
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 300,000,000 300,000,000
Common stock, shares issued 77,018,000 75,703,000
Common stock, shares outstanding 77,018,000 75,703,000
Series A Preferred Stock    
Preferred stock, shares authorized 1,684,000 1,684,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Series B Preferred Stock    
Preferred stock, shares authorized 1,581,000 1,581,000
Preferred stock, shares issued 927,000 927,000
Preferred stock, shares outstanding 927,000 927,000
Non-voting common stock    
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 3,553,000 3,553,000
Common stock, shares issued 1,000 1,000
Common stock, shares outstanding 1,000 1,000
[1] Amounts derived from the audited financial statements for the year ended December 31, 2023.